ZUCCA, IGNAZIO ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 156.652
NA - Nord America 6.040
AS - Asia 2.951
SA - Sud America 368
AF - Africa 75
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 166.101
Nazione #
IT - Italia 154.737
US - Stati Uniti d'America 5.923
SG - Singapore 1.104
CN - Cina 1.099
SE - Svezia 533
UA - Ucraina 496
BR - Brasile 288
VN - Vietnam 269
FI - Finlandia 203
GB - Regno Unito 183
DE - Germania 173
FR - Francia 142
HK - Hong Kong 91
IN - India 82
BD - Bangladesh 63
CA - Canada 63
NL - Olanda 42
KR - Corea 41
AR - Argentina 32
JP - Giappone 27
RU - Federazione Russa 26
ID - Indonesia 23
MX - Messico 21
PK - Pakistan 20
TR - Turchia 20
ZA - Sudafrica 20
IQ - Iraq 19
EG - Egitto 18
BE - Belgio 17
ES - Italia 13
RO - Romania 12
AU - Australia 11
IL - Israele 11
SA - Arabia Saudita 11
AT - Austria 10
CO - Colombia 10
PL - Polonia 10
EC - Ecuador 9
JM - Giamaica 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
LT - Lituania 7
MY - Malesia 7
TN - Tunisia 7
UZ - Uzbekistan 7
AL - Albania 6
CL - Cile 6
KE - Kenya 6
PE - Perù 6
TH - Thailandia 6
VE - Venezuela 6
AZ - Azerbaigian 5
BO - Bolivia 5
CH - Svizzera 5
CR - Costa Rica 5
DK - Danimarca 5
PA - Panama 5
PY - Paraguay 5
GR - Grecia 4
IE - Irlanda 4
IR - Iran 4
JO - Giordania 4
LB - Libano 4
MA - Marocco 4
PH - Filippine 4
PT - Portogallo 4
DO - Repubblica Dominicana 3
EU - Europa 3
NP - Nepal 3
OM - Oman 3
RS - Serbia 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BH - Bahrain 2
CG - Congo 2
CM - Camerun 2
EE - Estonia 2
ET - Etiopia 2
GT - Guatemala 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MU - Mauritius 2
NA - Namibia 2
NI - Nicaragua 2
PR - Porto Rico 2
AO - Angola 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DZ - Algeria 1
GD - Grenada 1
GL - Groenlandia 1
GP - Guadalupe 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
Totale 166.088
Città #
Cagliari 148.156
Uta 6.146
Singapore 557
Ashburn 479
Chandler 455
Woodbridge 437
San Jose 365
Nyköping 341
Fairfield 326
Ann Arbor 311
Houston 298
Boardman 273
Dallas 268
Jacksonville 255
Beijing 218
Wilmington 216
Dearborn 166
Seattle 139
Cambridge 125
Helsinki 119
Los Angeles 113
Nanjing 101
Santa Clara 101
Ho Chi Minh City 87
New York 86
The Dalles 84
Hong Kong 80
Lauterbourg 76
Boston 75
Hefei 70
Shanghai 64
Hanoi 56
Buffalo 46
Council Bluffs 46
Seoul 39
Redwood City 38
Nanchang 36
Rome 33
São Paulo 33
Guangzhou 32
Tianjin 32
Hebei 27
Milan 26
Toronto 26
Changsha 24
Frankfurt am Main 24
Shenyang 24
Orem 23
Dong Ket 22
Sassari 22
Jiaxing 21
San Diego 20
Tokyo 19
Atlanta 18
Chicago 18
Zhengzhou 18
Brussels 17
London 17
Munich 17
Haiphong 15
Jinan 15
Phoenix 15
San Francisco 15
Manchester 14
Chennai 13
Mumbai 13
Orange 13
Pune 13
Amsterdam 12
Ningbo 12
Columbus 11
Rio de Janeiro 11
Stockholm 11
Norwalk 10
Verona 10
Washington 10
Baghdad 9
Denver 9
Dhaka 9
Falls Church 9
Johannesburg 9
Montreal 9
Mountain View 9
Düsseldorf 8
Mexico City 8
Warsaw 8
Wuhan 8
Brooklyn 7
Da Nang 7
Kunming 7
Ottawa 7
Porto Alegre 7
Redondo Beach 7
San Mateo 7
Turku 7
Ankara 6
Auburn Hills 6
Augusta 6
Belo Horizonte 6
Chengdu 6
Totale 161.755
Nome #
Ace I and ACE II: immunohistochemical study in primary pterygium and primary cultures from pterygium 4.604
Immunohistochemical analysis of angiotensin converting enzyme in Sardinian pterygium 3.878
Angiotensin-converting-enzyme (ACE) insertion/deletion (I/D) polymorphism and pterygium. A case-control study in Sardinian population 3.768
null 3.645
Retinal Pigment Epithelium Changes in Autosomal dominant butterfly-shaped macular dystrphy with deletion in the periferin/RDS gene 3.567
Subclinical ocular alterations in thyroid eye disease. An additional score to predict the progression of disease 3.542
Subclinical alterations of extraocular muscles in Graves' Disease 3.527
Vitamin D and vitamin D receptor in patients with ophthalmic pterygium 3.459
Angiotensin II: immunohistochemical study in Sardinian pterygium 3.377
Identification of telocytes in the lamina propria of pterygium: an immunohistochemical and transmission electron microscopy study. 3.377
Familial strabismus in Sardinia 3.289
Morphologic, immunophenotypic, and ultrastructural characterization of telocytes in pterygium 3.174
Immunophenotypic characterization of telocyte-like cells in pterygium 3.117
Efficacy of oral acetazolamide and topical dorzolamide therapy for X-linked juvenile retinoschisis maculopathy 3.113
Treatment With Oral Acetazolamide Or Topic Dorzolamide Of Juvenile X-linked Retinoschisis 3.096
Pterygium and glucose-6-phosphate dehydrogenase deficiency 2.871
Immunohistochemical detection of Vitamin D receptor in pterygium 2.850
Innovative single-armed suture technique for Strabismus surgery 2.760
A novel OCT technique to measure in vivo the corneal adhesiveness for sodium carboxymethylcellulose in humans and its validity in the diagnosis of dry eye 2.758
Sistema immune locale nel melanoma della congiuntiva 2.747
Shifting and sliding of medial-inferior conjunctival flap for surgical treatment of Pterygium 2.714
null 2.678
Humphrey visual field 10-2 and macular retinal thickness correlations in glaucomatous patients. 2.672
ACE I and ACE II: immunohistochemical study in primary pterygium 2.667
null 2.585
null 2.413
Qualitative and quantitative analysis of filtering blebs with optical coherence tomography 2.396
Vision-related quality of life and symptom perception change over time in newly-diagnosed primary open angle glaucoma patients 2.334
The role of axial length (AxL) in planning strabismus surgery 2.284
Modificazione della IOP dopo intervento di Facoemulsificazione in pazienti affetti da GPAA 2.279
A NR2E3 Mutation (R309G) Associated With a Mild Form of Enhanced S-Cone Syndrome 2.233
Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma Study 2.233
The role of uric acid in the pathogenesis of primary open angle glaucoma 2.128
Risultati preliminari di uno studio longitudinale in pazienti affetti da morbo di Basedow con alterazioni subcliniche dei muscoli oculari. 2.101
A NOVEL MUTATION IN TRP1 GENE IN AN OCULAR CUTANEOUS ALBINISM PATIENT 2.000
null 1.996
A parafoveal ring of autofluorescence is a marker of disease in a large family with autosomal dominant sector RP associated with rhodopsin gene codon 190 mutation 1.981
Successful ustekinumab treatment of noninfectious uveitis and concomitant severe psoriatic arthritis and plaque psoriasis 1.961
mRNA Level Alterations Of Protein Involved In Cholesterol Ester Metabolism In Pterygium Fibroblast 1.912
High prevalence of subclinical extraocular muscles alterations in graves’ disease patients asymptomatic for active graves’orbitopathy 1.810
Colour vision deficiencies in two unrelated Sardinian families with butterfly-shaped macular dystrophy 1.768
Finding of conjunctival melanocytic pigmented lesions within pterygium 1.759
Photodynamic Therapy with Verteporfin for Corneal Neovascularization 1.719
Elevata prevalenza di alterazioni subcliniche dei muscoli extraoculari in pazienti con morbo di Basedow asintomatici per oftalmopatia attiva. 1.715
Genetic mapping of dominant primary open-angle glaucoma (POAG) in Sardinia 1.592
null 1.586
Terapia Fotodinamica dello Pterigio con Verteporfina 1.545
Ricostruzione del canto palpebrale mediale 1.536
Oxidative stress and apoptosis markers in pterygium: immunohistochemical study 1.534
Analysis of Fundus Autofluorescence in Patients with Different Genotypes and Phenotypes of Retinitis Pigmentosa (RP) 1.448
Oxidative DNA damage and the relationship between p53 and 8-OHdG in pterygium 1.433
Colour Vision Deficiencies in two Sardinian families with butterfly-shaped macular distrophy 1.428
Clinical and genetic study of myopia in St. Peter island (Sardinia) 1.408
null 1.344
Clinical and genetic study of miopia in St. Peter Island (Sardinia) 1.341
A perifoveal ring of autofluorescence is a marker of disease in a large family with autosomal dominant sector RP associated with rhodopsin gene codon 190 mutation 1.335
Lo Strabismo Concomitante: Eredità o Familiarità? 1.332
Genetic mapping of autosomal dominant primary open-angle glaucoma (POAG) in Sardinia 1.244
Clinical and genetic study of myopia in St. Peter Island(Sardinia) 1.209
Genetic analysis of autosomal dominant primary open angle glaucoma in Sardinia 1.169
Oxidative stress in pterigium 1.151
Photodynamic therapy of pterygium with verteporfin: a preliminary report 1.077
null 1.035
Photodynamic therapy in human pterygium. A preliminar report 1.015
Unfavorable effect of photodynamic therapy for late subretinal neovascularization with chorioretinal anastomoses associated with idiopathic multiple serous detachments of the retinal pigment epithelium 1.009
Association between the ACE insertion/deletion polymorphism and pterygium in Sardinian patients: a population based case-control study 983
Photodynamic therapy of corneal neovascularization with verteporfin 981
Unfavorable effect of photodynamic therapy in a multiple detachment of pigment epithelium complicated by choroidal neovascularization 968
The presence of a local immune system in the upper blind and lower part of the human nasolacrimal duct 957
Immunohistochemical study of human pterygium 926
Association between the angiotensin-converting enzyme (ace) insertion/deletion (I/d) polymorphism and pterygium in sardinian patients 789
Photodynamic therapy with Verteporfin (Visudyne) for pterygium 777
Immunohistochemical detection of progenitor cells in pterygium 767
Immunohistochemical expression of angiogenesis markers in human pterygium 738
Epidemiologia e genetica del glaucoma primario ad angolo aperto familiare in Sardegna 710
Dacriocistorinostomia endoscopica endonasale primaria e di revisione: esperienza personale 685
Colour discrimination in long-term aphakia 665
Genetic study of Sardinian families with G6PD deficiency and colour vision defects 635
Immunohistochemical study of several components of reninangiotensin system in sardinian pterygium 629
Evaluation of frequency doubling perimetry in ocular hypertone 628
A qualitative and quantitative analysis of filtering blebs with optical coherence tomography in patients after primary trabeculectomy 588
Endoscopic dacryocystorhinostomy as surgical technique in revision dacryocystorhinostomy 587
Blue-yellow perimetry in patients with ocular hypertone 561
Visual function in patients affected by multiple sclerosis: visual field and colour vision 558
Colour Vision Deficiencies X 556
Risultati di un programma di prevenzione del glaucoma in un'area della Sardegna sud-occidentale 549
Valutazioni ergonomiche dei difetti acquisiti del senso cromatico nei pazienti affetti da glaucoma 538
Analysis of Fundus Autofluorescence in Patients With Different Genotypes and Phenotypes of Retinitis Pigmentosa (RP) 530
Il ruolo della diafanoscopia delle vie lacrimali negli interventi di dacriocistorinostomia endonasale endoscopica primaria e di revisione 525
Colour discrimination in congenital stationary night blindness 520
Color discrimination in long-term idiopathic central serous choroidopathy 507
Evaluation of efficacy and tolerability of Nilutamide and Buserelin in the treatment of advanced prostate cancer. 486
null 455
Pterygium Imaging By Fourier-domain Optical Coherence Tomography 433
null 336
Influence of Sociodemographic Factors on Disease Characteristics and Vision-related Quality of Life in Primary Open-angle Glaucoma Patients: The Italian Primary Open Angle Glaucoma Study (IPOAGS) 101
null 38
Totale 166.334
Categoria #
all - tutte 198.508
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 198.508


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.138 0 0 0 0 0 0 0 0 0 0 0 1.138
2021/20226.828 564 696 521 314 571 626 529 432 492 456 788 839
2022/202311.001 1.035 1.590 1.136 975 665 695 596 970 773 788 1.280 498
2023/202411.686 534 372 412 647 1.176 1.902 1.904 837 431 700 1.359 1.412
2024/202527.453 6.820 7.796 6.052 1.980 1.218 1.224 1.501 103 212 182 162 203
2025/20265.508 532 293 579 473 531 430 819 404 299 555 336 257
Totale 166.334